George Golumbeski's most recent trade in Sage Therapeutics Inc was a trade of 21,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Mural Oncology plc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 8,637 | 8,637 | - | - | Stock Option (right to buy) | |
| Sage Therapeutics Inc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 13,593 | 13,593 | - | - | Stock Options (Right to buy) | |
| Mural Oncology plc | George S. Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 15,334 | 15,334 | - | - | Stock Option (right to buy) | |
| Shattuck Labs Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 27,700 | 27,700 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Golumbeski George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 3,495 | 3,495 | - | - | Stock Options (Right to buy) | |
| Sage Therapeutics Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 40,258 | 40,258 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 2,108 | 2,108 | - | - | Stock Options (Right to buy) | |
| Sage Therapeutics Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,947 | 9,947 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | George Golumbeski | Director | Purchase of securities on an exchange or from another person at price $ 31.45 per share. | 05 May 2022 | 8,000 | 8,000 (0%) | 0% | 31.4 | 251,563 | Common Stock |
| Shattuck Labs Inc | George Golumbeski | Director | Purchase of securities on an exchange or from another person at price $ 3.63 per share. | 26 Apr 2022 | 28,330 | 54,613 | - | 3.6 | 102,838 | Common Stock |
| Shattuck Labs Inc | George Golumbeski | Director | Purchase of securities on an exchange or from another person at price $ 3.69 per share. | 21 Apr 2022 | 26,049 | 26,049 | - | 3.7 | 96,121 | Common Stock |
| Shattuck Labs Inc | George Golumbeski | Director | Purchase of securities on an exchange or from another person at price $ 3.67 per share. | 21 Apr 2022 | 234 | 26,283 | - | 3.7 | 859 | Common Stock |
| Sage Therapeutics Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 1,638 | 1,638 | - | - | Stock Options (Right to buy) | |
| Shattuck Labs Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2021 | 3,434 | 3,434 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 832 | 832 | - | - | Stock Options (Right to buy) | |
| Shattuck Labs Inc | George Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 1,286 | 1,286 | - | - | Stock Option (Right to Buy) |